Phase III studies to investigate survodutide for people living with obesity and overweightBoehringer Ingelheim and Zealand Pharma have initiated three Phase III trials investigating survodutide (also known as BI 456906) for...
First patient treated with SiPore21 for sustained diabetes and obesity controlThe first patient has been treated with Sigrid Therapeutics’ SiPore21, an innovative medical device designed for sustained diabetes and...
Study links GLP-1s with serious gastrointestinal conditionsGlucagon-like peptide-1 (GLP-1) agonists are associated with an increased risk of serious medical conditions including stomach paralysis,...
T2DM diagnosis at age 30 can reduce life expectancy by up to 14 yearsAn individual diagnosed with type 2 diabetes at age 30 years could see their life expectancy fall by as much as 14 years, an...
Worldwide audit finds testosterone replacement improves glycaemic control in men for up to two yearsReal-world data from an ongoing international audit of testosterone deficiency in men with type 2 diabetes, suggests that testosterone...
ASMBS appoints Diane Enos as new Executive DirectorThe American Society for Metabolic and Bariatric Surgery (ASMBS), the nation’s largest professional organisation of bariatric and...
Dose-dependent link between the use of semaglutide and liraglutide injectables and body contouring procedures21 hours ago